WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
SOMERSET, N.J.–(BUSINESS WIRE)–WhizAI, the first and only augmented analytics platform purpose built for the life sciences and healthcare industries, has announced it has completed a new round of funding bringing total funding since launching in 2017 to $21 million. The company received investment from strategic investors Shanda Group and AmerisourceBergen’s AB Health Ventures, with participation from existing investors like Vertical Venture Partners and Healthy Ventures.
You might also interested in
-
Foundation Capital Invests in Vibe Capital, a New Venture Firm Built for Scrappy International Founders
Limited partners in Vibe Capital include Bessemer Venture Partners, Tribe Capital and Foundation Capital, as well as individuals including GSV […] -
Digital therapy maker Pear Therapeutics shakes the money tree, with plans to go public in $1.6B SPAC deal
One of Shanda’s portfolio companies, the digital treatment developer Pear Therapeutics, is taking the SPAC track, going public through a […] -
Hustle Fund Raises $33.6 Million To Democratize Access To Pre-Seed Capital
Shanda Group was happy to “re-up” for Hustle Fund’s second fund, which is about three times larger than its first. […]